APA (7th ed.) Citation

E, T., A, M., A, K., A, C., E, M., N, G., . . . NA, V. (2002). Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: A phase II trial in 281 patients. British journal of haematology, 118(1), 174. https://doi.org/10.1046/j.1365-2141.2002.03583.x

Chicago Style (17th ed.) Citation

E, Terpos, et al. "Prolonged Administration of Erythropoietin Increases Erythroid Response Rate in Myelodysplastic Syndromes: A Phase II Trial in 281 Patients." British Journal of Haematology 118, no. 1 (2002): 174. https://doi.org/10.1046/j.1365-2141.2002.03583.x.

MLA (9th ed.) Citation

E, Terpos, et al. "Prolonged Administration of Erythropoietin Increases Erythroid Response Rate in Myelodysplastic Syndromes: A Phase II Trial in 281 Patients." British Journal of Haematology, vol. 118, no. 1, 2002, p. 174, https://doi.org/10.1046/j.1365-2141.2002.03583.x.